NCT01808716

Brief Summary

The study hypothesis is a decreased muscle damage induced by exercises when low-level laser therapy is applied on body muscles before exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Feb 2011

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 11, 2013

Completed
Last Updated

March 11, 2013

Status Verified

March 1, 2013

Enrollment Period

8 months

First QC Date

March 1, 2013

Last Update Submit

March 7, 2013

Conditions

Keywords

low-level laser therapymuscle damage

Outcome Measures

Primary Outcomes (1)

  • Creatine Kinase analysis in blood

    Evaluation of Creatine Kinase (CK) levels in blood before, immediately after and 24h, 48h and 72h after protocol of exercise to induce muscle damage

    72 hours

Study Arms (2)

Low-level laser therapy (LLLT) on muscle damage

ACTIVE COMPARATOR

Effects of low-level laser therapy (LLLT)on muscle damage

Device: Low-level laser therapy (808nm) and exercise

Low-level laser therapy (LLLT) placebo on muscle damage

ACTIVE COMPARATOR

Effects of low-level laser therapy (LLLT) placebo on muscle damage

Device: Low-level laser therapy (808nm) and exercise

Interventions

Use of low-level laser therapy(LLLT)or placebo-LLLT applied on biceps brachii for muscle damage recovery

Also known as: Laser device (808nm; 100mW; DMC®, Brazil), Low-level laser therapy, Muscle damage, Muscle recovery
Low-level laser therapy (LLLT) on muscle damageLow-level laser therapy (LLLT) placebo on muscle damage

Eligibility Criteria

Age25 Years - 35 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • healthy males,
  • physically active,
  • aged between 25-40 years.

You may not qualify if:

  • smoker, or
  • under medicine as anti-inflammatory and/or any drug that could affect normal and physiological conditions and lesion in upper limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal Univesity of Rio Grande do Norte

Natal, Rio Grande do Norte, 59072-970, Brazil

Location

Related Publications (2)

  • Vieira WH, Ferraresi C, Perez SE, Baldissera V, Parizotto NA. Effects of low-level laser therapy (808 nm) on isokinetic muscle performance of young women submitted to endurance training: a randomized controlled clinical trial. Lasers Med Sci. 2012 Mar;27(2):497-504. doi: 10.1007/s10103-011-0984-0. Epub 2011 Aug 26.

    PMID: 21870127BACKGROUND
  • Ferraresi C, de Brito Oliveira T, de Oliveira Zafalon L, de Menezes Reiff RB, Baldissera V, de Andrade Perez SE, Matheucci Junior E, Parizotto NA. Effects of low level laser therapy (808 nm) on physical strength training in humans. Lasers Med Sci. 2011 May;26(3):349-58. doi: 10.1007/s10103-010-0855-0. Epub 2010 Nov 18.

    PMID: 21086010BACKGROUND

MeSH Terms

Interventions

Low-Level Light TherapyExercise TherapyLasers

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapyRehabilitationAftercareContinuity of Patient CarePatient CarePhysical Therapy ModalitiesOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Wouber Hérickson de Brito Vieira, PhD

    Universidade Federal do Rio Grande do Norte

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cleber Ferraresi

Study Record Dates

First Submitted

March 1, 2013

First Posted

March 11, 2013

Study Start

February 1, 2011

Primary Completion

October 1, 2011

Study Completion

June 1, 2012

Last Updated

March 11, 2013

Record last verified: 2013-03

Locations